APPLICATIONS OF KNOWN AND NOVEL CANNABINOIDS

The invention provides use of a medicament as a single agent, binary agent, or other combination comprising of substantially pure novel cannabinoids 1 and 2, optionally admixed with one or more known and novel cannabinoids and other known naturally occurring and synthetic tetracyclic 2A and tricycli...

Full description

Saved in:
Bibliographic Details
Main Authors BERKOWITZ BARRY A, BARRETT ANTHONY G, ELLIOTT DANIEL
Format Patent
LanguageChinese
English
Published 23.07.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides use of a medicament as a single agent, binary agent, or other combination comprising of substantially pure novel cannabinoids 1 and 2, optionally admixed with one or more known and novel cannabinoids and other known naturally occurring and synthetic tetracyclic 2A and tricyclic 1A cannabinoids for the prevention, treatment or cure of inflammatory mediated diseases or inflammatory mediated pathological conditions, anorexia, arthritis, cancer, pain, glaucoma, migraine, persistent muscle spasms, seizures (epileptic seizures), severe nausea, PTSD, autism spectrum disorder, drug abuse, insomnia, or any other chronic or persistent medical symptom. 本发明提供了药物作为单一药剂、二元药剂或其他组合的用途,所述药物包含基本上纯的新型大麻素1和2,任选地与一种或多种已知及新型大麻素及其他已知的天然存在及合成的四环2A和三环1A大麻素混合,用于预防、治疗或治愈炎症介导的疾病或炎症介导的病理状态、厌食、关节炎、癌症、疼痛、青光眼、偏头痛、持续性肌痉挛、惊厥发作(癫痫发作)、重度恶心、PTSD、自闭症谱系障碍、药物滥用、失眠或任何其他慢性或持续性证候。
Bibliography:Application Number: CN201980060466